Home
About Us
Products
Manus Aktteva Biopharma LLP, an ISO 9001: 2008 certified sourcing & export concern takes pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.
Category
Recommended
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Enquiry
Quick Links
Careers
Contact Us

Sumatriptan

Manus Aktteva Biopharma LLP, a global supplier of Sumatriptan, 103628-46-2 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.

CAS number:

103628-46-2

Chemical Name:

1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptan

Pharmacopeia:

USP, EP, BP

Certificate:

GMP, cGMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico, Korea FDA

Application:

For R&D Purpose

Properties
Related Intermediates

Synonym

1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptan

Molecular Formula

C14H21N3O2S

Molecular Weight

295.40

Specifications

Available on request

Packing

Export worthy packing

Material Safety Data Sheet

Available on request

Comments

Sumatriptan Base : Anti Migraine : Sumatriptan is metabolised primarily by monoamine oxidase A into an indole acetic acid analogue, part of which is further conjugated with glucuronic acid.

Product Name	CAS No.
Sodium cyanoborohydride	25895-60-7	View \| Inquire
4,4-Diethoxy-N,N-dimethyl-1-butanamine	1116-77-4	View \| Inquire
4-Chlorobutanal diethyl acetal	6139-83-9	View \| Inquire
N-Methyl-4-diazanylsulfabenzamide	88933-16-8	View \| Inquire
Sodium 4-chloro-1-hydroxybutanesulfonate	54322-20-2	View \| Inquire
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide	88919-22-6	View \| Inquire
4-Hydrazino-N-methylbenzenemethanesulfonamide	139272-29-0	View \| Inquire

Description:

Sumatriptan, CAS NO 103628-46-2, is a synthetic drug belonging to the triptan class, used for the treatment of migraine headaches. Sumatriptan is used to treat migraines. It helps to relieve headaches, pain and other symptoms of migraines, including sensitivity to light/sound, nausea, and vomiting. Sumatriptan succinate constricts bloodvessels and is used to treat migraine attacks. During migraine attacks certain bloodvessels in the brain become enlarged and this causes pain. Manus Aktteva Biopharma LLP, a global supplier of Oxyclozanide offers for your requirements with supportive technical package equired for evaluation.

Documentation / Approvals :

USDMF	EDMF	CEP / COS	TDP	DMF - CTD	ICH

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.

Are you looking for Sumatriptan with documentation like PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (OPEN PART), DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, COPP, TDMF, Written Confirmation? Please click here to send us sourcing request.

Why Us